Clinical Data and Trial Management Services and Solutions Organization Leverages Medidata Rave Web Services API to Enable Data Sharing Between ClinPlus CTMS and Medidata Rave EDC/CDM
New York, NY/Bound Brook, NJ - April 6, 2011 - Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, and DZS Software Solutions, a specialty provider of clinical data and trial management software services and solutions, today announced the addition of DZS to Medidata's Technology Partner Program. The partnership recognizes that DZS has enhanced its ClinPlus® clinical trial management system (CTMS) to automatically share trial data with the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform using its Web Services API, eliminating redundant data entry.
DZS works with a range of biotechnology and pharmaceutical organizations worldwide who are trying to improve clinical data and trial management using best-of-breed clinical technologies. In response, DZS has introduced a new version of their ClinPlus CTMS with new functionality that helps overcome a common, complex challenge of sharing trial data between EDC systems and trial management systems. With an efficient and error-free method of bringing trial data captured within Medidata Rave into ClinPlus CTMS, DZS is now better able to serve customers with rapid, automated transfers of trial data, such as patient enrollment, patient visit, dropout and discontinuance data.
Clinical trial sponsors can now utilize both solutions together to further improve trial efficiencies, including faster availability of comprehensive trial data to help reduce redundant or incorrect investigator, patient enrollment and site visit data and support better decision making. With earlier access to patient milestone data, sponsors have the ability to make more timely payments to investigators, which contributes to site satisfaction and retention.
"DZS continues to focus on improving clinical trial productivity in all phases of the clinical trial process by using technologies that leverage the value of trial data and improve the quality of that data to support regulatory approval for new compounds and medical devices. Our partnership with Medidata Solutions positions DZS to take advantage of a leading EDC breakthrough solution that is quickly becoming a major force in the drug development arena," said Doron Steger, CEO, DZS Software Solutions.
Since its introduction in June of 2009, Medidata's Technology Partner Program has grown to include 12 independent technology vendors that offer specialized solutions supporting data sharing with Medidata products in order to streamline and enhance the end-to-end e-Clinical process.
"We welcome DZS as a Medidata Technology Partner and are excited that our customers have the choice of leveraging DZS' easily configurable solution to streamline their trial management activities," said Glen de Vries, president, Medidata Solutions. "DZS designed their solution for customers around the globe who are increasingly looking to efficiently use an advanced CTMS solution alongside Medidata Rave."
To speak to a product expert or arrange a personalized demonstration, please contact [email protected] or follow this link to request specific information or pricing: http://tinyurl.com/4hwgtmk
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found in every system!
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers' clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Medidata's advanced solutions address key functions throughout the clinical development process including protocol development (Medidata Designer®), trial planning and management (Medidata Grants Manager®, Medidata CRO Contractor®), user and learning management (iMedidataTM), randomization and trial supply management (Medidata BalanceTM), monitoring (Medidata Rave Monitor, Medidata Rave Targeted SDV), Serious Adverse Events capture (Medidata Rave Safety Gateway) and clinical data capture, management and reporting (Medidata Rave®). Our diverse customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.